Metformin | ||
| Egyptian Pharmaceutical Journal | ||
| Volume 19, Issue 2, April 2020, Pages 81-86 PDF (377.89 K) | ||
| DOI: 10.4103/epj.epj_50_19 | ||
| Authors | ||
| Mohammad Asif; Mrityunjoy Acharya; Mohd Imran | ||
| Abstract | ||
At present metformin is the core for the management of type-2 diabetes mellitus. The key clue of metformin as a hypoglycemic drug was collected from the traditional utilization of for the management of diabetes. Modern study recommends several valuable activities of Metformin other than the hypoglycemic effect such as type-1 diabetes mellitus, polycystic ovary syndrome, cholesterol-lowering effect, avoidance of heart disease, age, cancer, and neuroprotection. In the present review, we are discussing about the source and versatile utilization of metformin and its outcome. | ||
| Keywords | ||
| Cancer; Diabetes mellitus; Metformin; neuroprotective; polycystic ovary syndrome; Traditional use; Type-1 Diabetes Mellitus; Type-2 diabetes mellitus | ||
|
Statistics Article View: 78 PDF Download: 43 |
||
